视网膜新前沿：2020年血管生成、渗出与变性研讨会亮点
New Frontiers in Retina: highlights of the 2020 angiogenesis, exudation and degeneration symposium.
作者信息
Puliafito Carmen A, Wykoff Charles C
机构信息
Retinal Synthesis LLC, Pasadena, CA USA.
2Houston Methodist Hospital, Weill Cornell Medical School, Houston, TX USA.
出版信息
Int J Retina Vitreous. 2020 May 22;6:18. doi: 10.1186/s40942-020-00221-4. eCollection 2020.
Abstract
We summarize the most important findings presented at the 2020 angiogenesis, exudation and degeneration symposium in five topic areas: (1) epidemiology of retinal vascular disease and macular degeneration; (2) dry AMD and geographic atrophy; (3) neovascular age-related macular degeneration; (4) drug delivery and devices and (5) diabetic retinopathy.
摘要
我们在五个主题领域总结了2020年血管生成、渗出和变性研讨会上展示的最重要研究结果：（1）视网膜血管疾病和黄斑变性的流行病学；（2）干性年龄相关性黄斑变性和地图状萎缩；（3）新生血管性年龄相关性黄斑变性；（4）药物递送与器械；以及（5）糖尿病视网膜病变。
相似文献
1
New Frontiers in Retina: highlights of the 2020 angiogenesis, exudation and degeneration symposium.视网膜新前沿：2020年血管生成、渗出与变性研讨会亮点
Int J Retina Vitreous. 2020 May 22;6:18. doi: 10.1186/s40942-020-00221-4. eCollection 2020.
2
Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration.载非诺贝特可生物降解纳米粒治疗实验性糖尿病视网膜病变和新生血管性年龄相关性黄斑变性。
Mol Pharm. 2019 May 6;16(5):1958-1970. doi: 10.1021/acs.molpharmaceut.8b01319. Epub 2019 Mar 26.
3
Neovascular age-related macular degeneration: advancement in retinal imaging builds a bridge between histopathology and clinical findings.新生血管性年龄相关性黄斑变性：视网膜影像学的进步在组织病理学和临床发现之间架起了桥梁。
Graefes Arch Clin Exp Ophthalmol. 2022 Jul;260(7):2087-2093. doi: 10.1007/s00417-022-05577-x. Epub 2022 Feb 5.
4
Innate Immunity in Age-Related Macular Degeneration.年龄相关性黄斑变性中的先天免疫。
Adv Exp Med Biol. 2021;1256:121-141. doi: 10.1007/978-3-030-66014-7_5.
5
Imaging and artificial intelligence for progression of age-related macular degeneration.与年龄相关的黄斑变性的影像学和人工智能。
Exp Biol Med (Maywood). 2021 Oct;246(20):2159-2169. doi: 10.1177/15353702211031547. Epub 2021 Aug 18.
6
Phase 1 Clinical Trial of Elamipretide in Dry Age-Related Macular Degeneration and Noncentral Geographic Atrophy: ReCLAIM NCGA Study.依拉米肽治疗干性年龄相关性黄斑变性和非中心性地图样萎缩的1期临床试验：ReCLAIM NCGA研究
Ophthalmol Sci. 2021 Nov 27;2(1):100086. doi: 10.1016/j.xops.2021.100086. eCollection 2022 Mar.
7
Evolution of oxidative stress, inflammation and neovascularization in the choroid and retina in a subretinal lipid induced age-related macular degeneration model.在亚视网膜脂质诱导的年龄相关性黄斑变性模型中，脉络膜和视网膜中的氧化应激、炎症和新生血管的演变。
Exp Eye Res. 2021 Feb;203:108391. doi: 10.1016/j.exer.2020.108391. Epub 2020 Dec 8.
8
Volume Rendering of Deep Retinal Age-Related Microvascular Anomalies.深度视网膜年龄相关性微血管异常的容积再现
Ophthalmol Retina. 2022 Dec;6(12):1185-1193. doi: 10.1016/j.oret.2022.06.005. Epub 2022 Jun 27.
9
The Placental Growth Factor Pathway and Its Potential Role in Macular Degenerative Disease.胎盘生长因子通路及其在退行性黄斑病变中的潜在作用。
Curr Eye Res. 2019 Aug;44(8):813-822. doi: 10.1080/02713683.2019.1614197. Epub 2019 May 24.
10
Co-existence of Age-Related Macular Degeneration and Diabetic Retinopathy in a Tertiary Referral Center in Greece.希腊一家三级转诊中心年龄相关性黄斑变性与糖尿病视网膜病变的共存情况
Cureus. 2022 Nov 3;14(11):e31051. doi: 10.7759/cureus.31051. eCollection 2022 Nov.
引用本文的文献
1
Novel therapies for proliferative retinopathies.增殖性视网膜病变的新型疗法。
Ther Adv Chronic Dis. 2022 Dec 2;13:20406223221140395. doi: 10.1177/20406223221140395. eCollection 2022.
2
Current and Future Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration.用于治疗新生血管性年龄相关性黄斑变性的当前及未来抗血管内皮生长因子药物
J Exp Pharmacol. 2021 Sep 29;13:905-912. doi: 10.2147/JEP.S259298. eCollection 2021.
3
Pitavastatin stimulates retinal angiogenesis via HMG-CoA reductase-independent activation of RhoA-mediated pathways and focal adhesion.培伐他汀通过 HMG-CoA 还原酶非依赖性激活 RhoA 介导的途径和黏着斑刺激视网膜血管生成。
Graefes Arch Clin Exp Ophthalmol. 2021 Sep;259(9):2707-2716. doi: 10.1007/s00417-021-05328-4. Epub 2021 Jul 30.
4
Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration.抗血管内皮生长因子治疗在新生血管性年龄相关性黄斑变性中的预测概率。
Transl Vis Sci Technol. 2021 Jun 1;10(7):30. doi: 10.1167/tvst.10.7.30.
5
Suprachoroidal Delivery of Small Molecules, Nanoparticles, Gene and Cell Therapies for Ocular Diseases.用于眼部疾病的小分子、纳米颗粒、基因和细胞疗法的脉络膜上腔给药
Pharmaceutics. 2021 Feb 22;13(2):288. doi: 10.3390/pharmaceutics13020288.
6
Development and applications of artificial symmetrical proteins.人工对称蛋白质的开发与应用
Comput Struct Biotechnol J. 2020 Nov 27;18:3959-3968. doi: 10.1016/j.csbj.2020.10.040. eCollection 2020.
7
Targeting complement components C3 and C5 for the retina: Key concepts and lingering questions.靶向视网膜中的补体成分 C3 和 C5：关键概念和遗留问题。
Prog Retin Eye Res. 2021 Jul;83:100936. doi: 10.1016/j.preteyeres.2020.100936. Epub 2020 Dec 13.
本文引用的文献
1
Natural History of Geographic Atrophy Secondary to Age-Related Macular Degeneration: Results from the Prospective Proxima A and B Clinical Trials.年龄相关性黄斑变性继发地图状萎缩的自然病程：前瞻性 Proxima A 和 B 临床试验结果。
Ophthalmology. 2020 Jun;127(6):769-783. doi: 10.1016/j.ophtha.2019.12.009. Epub 2019 Dec 14.
2
Quantification of Choriocapillaris with Phansalkar Local Thresholding: Pitfalls to Avoid.用 Phansalkar 局部阈值法对脉络膜毛细血管进行定量分析：应避免的陷阱。
Am J Ophthalmol. 2020 May;213:161-176. doi: 10.1016/j.ajo.2020.02.003. Epub 2020 Feb 12.
3
Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial.培塞利珠单抗治疗与年龄相关的黄斑变性相关性地图状萎缩的 2 期随机临床试验
Ophthalmology. 2020 Feb;127(2):186-195. doi: 10.1016/j.ophtha.2019.07.011. Epub 2019 Jul 16.
4
Widefield Swept-Source Optical Coherence Tomography Angiography of Proliferative Diabetic Retinopathy.增殖性糖尿病视网膜病变的广角扫频源光学相干断层扫描血管造影
Ophthalmic Surg Lasers Imaging Retina. 2019 Aug 1;50(8):474-484. doi: 10.3928/23258160-20190806-01.
5
AAV8-vectored suprachoroidal gene transfer produces widespread ocular transgene expression.腺相关病毒 8 载体脉络膜上腔基因转移可产生广泛的眼部转基因表达。
J Clin Invest. 2019 Aug 13;129(11):4901-4911. doi: 10.1172/JCI129085.
6
Looking ahead in retinal disease management: .展望视网膜疾病的管理：
Int J Retina Vitreous. 2019 May 29;5:22. doi: 10.1186/s40942-019-0174-y. eCollection 2019.
7
The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration: Results from the Randomized Phase 2 Ladder Clinical Trial.雷珠单抗玻璃体腔注射给药系统治疗新生血管性年龄相关性黄斑变性的随机 2 期临床试验结果
Ophthalmology. 2019 Aug;126(8):1141-1154. doi: 10.1016/j.ophtha.2019.03.036. Epub 2019 Apr 1.
8
Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized Trial.贝伐珠单抗联合雷珠单抗治疗糖尿病黄斑水肿的多中心、随机、双盲、假手术对照 2 期临床试验
Ophthalmology. 2019 Aug;126(8):1155-1170. doi: 10.1016/j.ophtha.2019.03.023. Epub 2019 Mar 21.
9
DeepSeeNet: A Deep Learning Model for Automated Classification of Patient-based Age-related Macular Degeneration Severity from Color Fundus Photographs.深见网络：一种基于深度学习的用于自动分类基于患者的年龄相关性黄斑变性严重程度的彩色眼底照片的模型。
Ophthalmology. 2019 Apr;126(4):565-575. doi: 10.1016/j.ophtha.2018.11.015. Epub 2018 Nov 22.
10
Natural History of Subclinical Neovascularization in Nonexudative Age-Related Macular Degeneration Using Swept-Source OCT Angiography.应用扫频源 OCT 血管造影术观察非渗出性年龄相关性黄斑变性的亚临床新生血管自然史。
Ophthalmology. 2018 Feb;125(2):255-266. doi: 10.1016/j.ophtha.2017.08.030. Epub 2017 Sep 28.
Zotero 插件